Case study

Zentiva

Zentiva brand artwork
Client
Zentiva
Sector
Pharma, Tech
Location
Prague, CZ
Services
Editorial, Social
Year
2021

High-quality, affordable medicines for everyone.

Zentiva logo construction
Overview

Zentiva is a pan-European leader in generic and branded generic medicines, headquartered in Prague with roots reaching back to a pharmacy founded there in 1488. Developing and manufacturing over 2,650 products across major therapeutic areas, the company serves more than 100 million patients in over 30 countries, championing high-quality, affordable healthcare for all generations.

Colour palette

Zentiva's fresh green, backed by a calm, clinical supporting cast.

#00BD8E
#C4DDEB
#262626
#0744FE
Social

Story cards that set the market numbers beside the promise they back up.

Zentiva

High-quality,
affordable medicines.

100 million people.
+40 countries.

Zentiva
Zentiva
Zentiva
Total market value 2020
€8.6B
Generics and originator categories combined across the market.
Volume Q4 2020
19.6M
Standard units in the generics segment.
Zentiva patient-guide brochure
Presentations

Market analysis and strategy for Spain, redesigned into clear, confident slides.

STRATEGIC PLAN · ES

Zentiva ES
Strategic plan

June 2026
01
Market dynamics
Generic market in Spain
02
Findings
Value, volume and channels
03
Recommendations
Strategy carried out by Zentiva

The present report is an outline of market analysis dynamics to be considered when going through the findings and recommendations about the strategy in Spain to be carried out by Zentiva.

The present report is just only a high-level draft issued by the author and should not be considered as final strategy proposal since there is missing market information not available in the public domain.

Beach photograph
Oral solid dose — value forecastOSD CAGR 4.1%
2026202720282029203020312032
Oral solid dose — volume forecastOSD CAGR 1%
2026202720282029203020312032
FORECAST · 2026–2032

Oral solid dose stays the backbone of the Spanish generics market, with value growing at a 4.1% CAGR through 2032 as volume holds broadly flat at 1%.

Pre-filled syringes and other specialty formats gain share over the period, while oral long-acting formulations remain a steady contributor.

Oral ordinary
Pre-filled syringe
Injectable
Other
Oral long acting
IQVIA ForecastLink April 2021
SPANISH MARKET · Q4 2018–2020
Total market value and volume
Q4 2018
Q4 2019
Q4 2020

Total market value

Generics
Originator
No category
Others

Total market share volume

Generics
Originator
No category
Others
Glass bubbles artwork

High-quality, affordable medicines for everyone.

Health and wellbeing made accessible to more than 100 million people, every single day.

The present report is an outline of market dynamics to be considered when going through the findings and recommendations about the strategy in Spain to be carried out by Zentiva.

Zentiva report cover flower
Zentiva presentation on a laptop
Data visualisation

Data made legible on charts, infographics, and print pieces.

57%Generics
36%Originator
6%No category
1%Others
1 POINT = 1% OF VOLUMEN RX
Zentiva launches book
Zentiva report on a tablet

Durante más de 530 años, Zentiva ha sido un socio de confianza en el cuidado de la salud, y tenemos la responsabilidad de actuar hoy por un mañana sostenible, asegurando que Zentiva continúe proporcionando salud y bienestar para todas las generaciones, durante al menos otros 500 años.

Steffen Saltofte
Chief Executive Officer
Glass spheres photograph
Credits
Creative directionTailored
Presentation & editorial designTailored
Next project
Scroll down
Case study

Clear Project

Clear Project logo over a wireframe dental aligner
Client
Clear Project
Sector
Invisible orthodontics
Services
Branding, Web
Year
2025